Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol Myers Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business.
Source link
- Man arrested in France over murder of wife, four children, prosecutor says
- Nonprofit Code.org sues Byju’s unit WhiteHat Jr over payment dues | TechCrunch
